James G Krueger
Overview
Explore the profile of James G Krueger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
365
Citations
18537
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim J, Lee J, Lee J, Kim K, Li X, Zhou W, et al.
J Allergy Clin Immunol
. 2025 Feb;
PMID: 39978685
Background: Recent single-cell studies indicated that IL-17-producing T cells (T17) have diverse subsets expressing IL-17A, IL-17F, or a combination in human psoriasis skin. However, it is unknown how T17 subsets...
2.
Devine R, Capili B, Kost R, Krueger J, Coller B
J Clin Transl Sci
. 2025 Jan;
8(1):e222.
PMID: 39823112
There has been an erosion of trust in medical care and clinical research, and this has raised issues about whether institutions and investigators conducting clinical research are worthy of trust....
3.
Yu W, Barrett J, Tong J, Lin M, Marohn M, Devlin J, et al.
Immunity
. 2024 Dec;
57(12):2827-2842.e5.
PMID: 39662091
Hidradenitis suppurativa (HS) is a chronic, debilitating inflammatory skin disease characterized by keratinized epithelial tunnels that grow deeply into the dermis. Here, we examined the immune microenvironment within human HS...
4.
Zhang A, Ball G, Zundell M, Aguero R, Yee D, Shields A, et al.
J Drugs Dermatol
. 2024 Dec;
23(12):1114-1120.
PMID: 39630678
Background: International Dermatology Outcome Measures (IDEOM) is a non-profit organization whose mission is to improve the availability of evidence-based, consensus-driven outcome measures for dermatological diseases. IDEOM facilitates collaboration between stakeholders...
5.
Catlett I, Gao L, Hu Y, Banerjee S, Krueger J
Dermatol Ther (Heidelb)
. 2024 Sep;
14(10):2827-2839.
PMID: 39283417
Background: Psoriasis, a chronic, immune-mediated, inflammatory disease, affects 2‒3% of the population. Tyrosine kinase 2 (TYK2) mediates cytokine signaling involved in adaptive [interleukin (IL)-12, IL-23] and innate (type-I interferons) immune...
6.
Aguero R, Buchanan K, Navarrete-Dechent C, Marghoob A, Stein J, Landy M, et al.
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272935
Incorporation of dermoscopy and artificial intelligence (AI) is improving healthcare professionals' ability to diagnose melanoma earlier, but these algorithms often suffer from a "black box" issue, where decision-making processes are...
7.
Blauvelt A, Chen Y, Branigan P, Liu X, DePrimo S, Keyes B, et al.
JID Innov
. 2024 Sep;
4(5):100297.
PMID: 39224116
IL-23 is a cytokine produced by myeloid cells that drives the T helper 17 pathway and plays an essential role in the pathophysiology of plaque psoriasis. IL-23 activation initiates a...
8.
Shishido-Takahashi N, Garcet S, Cueto I, Miura S, Li X, Rambhia D, et al.
J Invest Dermatol
. 2024 Jul;
145(3):536-547.e7.
PMID: 39038532
Hidradenitis suppurativa (HS) is a chronic inflammatory disease that is difficult to control, and its mechanism remains unclear. Hepatocyte GF (HGF) has been reported to be significantly upregulated in the...
9.
Farag A, Visvanathan S, Bachelez H, Morita A, Lebwohl M, Barker J, et al.
J Invest Dermatol
. 2024 Jul;
145(3):573-582.e8.
PMID: 39004117
EFFISAYIL 1 was a randomized, placebo-controlled study of spesolimab, an anti-IL-36 receptor antibody, in patients presenting with a generalized pustular psoriasis flare. Treatment with spesolimab led to more rapid pustular...
10.
Czarnowicki T, David E, Yamamura K, Han J, He H, Pavel A, et al.
Allergy
. 2024 Jul;
79(10):2732-2747.
PMID: 39003573
Background: While B-cells have historically been implicated in allergy development, a growing body of evidence supports their role in atopic dermatitis (AD). B-cell differentiation across ages in AD, and its...